Tofasis 5 Tablet

Tofasis 5 Tablet Specification

Salt Composition
Tofacitinib 5 mg

Life Span
24 months from manufacturing date

Indication
Autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis

Packaging Type
Blister pack

Dosage Form
Oral tablet

Brand Name
Tofasis-5

Origin of Medicine
India

Pacakaging (Quantity Per Box)
10 strips per box

Drug Type
Allopathic

Ingredients
Tofacitinib 5 mg

Physical Form
Tablet

Function
Janus kinase (JAK) inhibitor for immunomodulation

Recommended For
Adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis

Dosage
As directed by physician

Dosage Guidelines
Take orally with or without food, as prescribed

Quantity
1 Strip (10 Tablets)

Storage Instructions
Store below 30C, protect from moisture and light

Administration Route
Oral

Approval
Approved by DCGI (India) and FDA (for specified indications)

Color
White

Marketed In
India and select export markets

Side Effects
Nausea, headache, upper respiratory tract infections, increased cholesterol, diarrhea

Prescription Required
Yes

Therapeutic Class
Immunosuppressants / Disease Modifying Antirheumatic Drug (DMARD)

Trade Name
Tofasis 5 mg Tablet

Shape
Round

Warning and Precautions
Use with caution in patients with infections, liver or kidney impairment, or history of tuberculosis

Tofasis 5 Tablet Trade Information

Minimum Order Quantity
300 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Tofasis 5 Tablet

Tofasis 5 Tablet is a featured laureate in the field of immunosuppressive therapeutics, designed for adults dealing with redoubtable autoimmune disorders like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Powered by Tofacitinib 5 mg, these soaring round, white oral tablets function as Janus kinase (JAK) inhibitors, providing redoubtable relief by modulating immune responses. Approved by DCGI and FDA, Tofasis-5 is marketed in India and select global markets. Buy online and enjoy potential discounts. Prescription is required. Use with caution and as strictly advised by your physician.

Application Surface & Therapeutic Areas

Tofasis 5 Tablet is administered orally, acting systemically to treat moderate to severe autoimmune conditions. It is particularly effective for application in adults suffering from rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Special features include its laureate JAK inhibitor function for targeted immunomodulation. The white, round tablets are suitable for adult use only and are integral for comprehensive autoimmune disorder management under physician supervision.

Packaging, Certification & Quick Dispatch

Tofasis 5 Tablets are packaged in secure blister packs, 10 strips per box, ensuring product integrity and extended lifespan of 24 months. Certified by DCGI India and approved for specified uses by the FDA, the product comes with guaranteed compliance. As a distributor, supplier, and exporter, we offer quick dispatch, minimizing your expenditure and ensuring timely delivery. Orders are efficiently dispatched to both domestic and select export markets with careful attention to safety.

FAQ's of Tofasis 5 Tablet:

Q: How should Tofasis 5 Tablet be administered?

A: Tofasis 5 Tablet should be taken orally, with or without food, following the dosage guidelines prescribed by your physician.

Q: What conditions are treated with Tofasis 5 Tablet?

A: This medication is indicated for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Q: When can I expect to receive my order of Tofasis 5 Tablets?

A: Orders are typically dispatched quickly upon confirmation and processed efficiently for both domestic and export delivery, ensuring timely arrival.

Q: What precautions should be observed while using Tofasis 5 Tablet?

A: Use with caution if you have infections, liver or kidney impairment, or a history of tuberculosis. Always consult your physician before starting therapy.

Q: Where is Tofasis 5 Tablet approved and supplied from?

A: Tofasis 5 Tablet is approved by DCGI in India and FDA for specific indications, manufactured and exported from India to select global markets.

Q: What are some possible side effects of this medication?

A: Possible side effects include nausea, headache, upper respiratory tract infections, increased cholesterol, and diarrhea. Immediately consult your physician if you notice any adverse effects.